Virtus ETF Advisers LLC Silence Therapeutics PLC Transaction History
Virtus ETF Advisers LLC
- $234 Million
- Q4 2024
A detailed history of Virtus ETF Advisers LLC transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 10,772 shares of SLN stock, worth $52,136. This represents 0.03% of its overall portfolio holdings.
Number of Shares
10,772
Previous 4,674
130.47%
Holding current value
$52,136
Previous $85,000
12.94%
% of portfolio
0.03%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding SLN
# of Institutions
67Shares Held
23.6MCall Options Held
300Put Options Held
2K-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$14.7 Million3.41% of portfolio
-
Siren, L.L.C. New York, NY2.83MShares$13.7 Million0.86% of portfolio
-
Redmile Group, LLC San Francisco, CA2.4MShares$11.6 Million1.29% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.86MShares$8.98 Million1.01% of portfolio
-
Morgan Stanley New York, NY1.66MShares$8.05 Million0.0% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $174M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...